#1PI EXTERNAL PI Industries Ltd Investor Presentation June, 2021 Pi Inspired by Science Certain statements made in this presentation may not be based on historical information or facts and may be "forward looking statements," including those relating to general business plans and strategy of PI Industries Limited ("PIIL"), its future outlook and growth prospects, and future developments in its businesses and its competitive and regulatory environment. Actual results may differ materially from these forward-looking statements due to a number of factors, including future changes or developments in PIIL's business, its competitive environment, its ability to implement its strategies and initiatives and respond to technological changes and political, economic, regulatory and social conditions in India. This presentation does not constitute a prospectus, offering circular or offering memorandum or an offer, or a solicitation of any offer, to purchase or sell, any shares and should not be considered as a recommendation that any investor should subscribe for or purchase any of PIIL's shares. Neither this presentation nor any other documentation or information (or any part thereof) delivered or supplied under or in relation to the shares shall be deemed to constitute an offer of or an invitation by or on behalf of PIIL. PIIL, as such, makes no representation or warranty, express or implied, as to, and does not accept any responsibility or liability with respect to, the fairness, accuracy, completeness or correctness of any information or opinions contained herein. The information contained in this presentation, unless otherwise specified is only current as of the date of this presentation. PIIL assumes no responsibility to publicly amend, modify or revise any forward looking statements, on the basis of any subsequent development, information or events, or otherwise. Unless otherwise stated in this document, the information contained herein is based on management information and estimates. The information contained herein is subject to change without notice and past performance is not indicative of future results. PIIL may alter, modify or otherwise change in any manner the content of this presentation, without obligation to notify any person of such revision or changes. This presentation may not be copied and disseminated in any manner. THE INFORMATION PRESENTED HERE IS NOT AN OFFER OR SOLICITATION OF ANY OFFER TO PURCHASE OR SELL ANY EQUITY SHARES OR ANY OTHER SECURITY OF PI INDUSTRIES LTD. CDR India Siddharth Rangnekar [email protected] Nishid Solanki [email protected] Tel: +91 22 6645 1221/1209 Fax: +9122 6645 1213 NOVITA BIOVITA SEAWEED fam OSHER VIBRANT NOM NEE OSHEEN FORRTOX-10G Rudol INRO LURIY WICKET PEMEX MELSA KITA TEFUP SANIPEB LOGIK ROKET PI Industries Limited Rajnish Sarna [email protected] Rajiv Batra [email protected] Tel: +91 124 6790000 Fax: +91 124 4081247#2PI EXTERNAL Performance Highlights Q4FY21 & FY21 Corrigendum f Inspired by Science#3PI EXTERNAL CONSOLIDATED Out-performance continued in Q4'FY21... Revenue up by 40%, EBITDA up by 22%.. PAT up by 62% YoY Fig in Crores Q4FY20 Q4FY21 % YOY Revenue 855 1,197 40% Gross Margin 47% 42% (470) bps Overheads 214 277 29% EBITDA 187 227 22% EBITDA as % Revenue 22% 19% (290) bps Net Profit 111 180 62% 683 47% 11 % 1006 172 191 227 187 22% 62% 180 111 ✓ 40% YoY revenue growth driven by.. Pi Inspired by Science ✓ ~47% growth in Exports contributed by Strong Volume growth in key products ✓ ~11% growth in Domestic in line with the business plan. Newly acquired Isagro registered impressive 51% YoY revenue growth ✓ Gross Profit improved by 26% YoY driven by higher revenue. Overall Gross Margin however softened on account of change in sales mix & reduced MEIS benefits ✓ EBITDA improved by 22% YoY due to higher revenue although the quarterly margin %age softened mainly on account of reduced gross margin despite operating leverage benefit ✓ Net profit improved by 62% YoY due to operationalization of new SEZ unit and reduced ETR ✓ Board recommends final dividend of Rs. 2/-Share EXPORTS DOMESTIC Q4FY20 Q4FY21 Q4 & FY21 Earnings Presentation EBITDA Q4FY20 PAT Q4FY21 3#4FY21 performance exceeded plan amid challenging conditions around Revenue up by 36%, EBITDA up by 41%.. PAT Up by 62% YoY CONSOLIDATED Fig in Crores FY20 FY21 % YOY Revenue 3,366 4,577 36% Gross Margin 45% 44% (~100)bps Overheads 801 994 24% EBITDA 719 1017 41% EBITDA as % Revenue 21% 22% 90 bps Net Profit 457 738 62% 41% 62% 35% 39% 3322 2466 EXPORTS FY20 719 1255 900 DOMESTIC FY21 1017 457 PAT EBITDA FY20 FY21 738 Pi Inspired by Science ✓ Proactive measures taken in supply chain and operations planning lead to limited Covid-19 disruption ✓ ~36% YoY revenue growth mainly driven by ✓ ~35% YoY growth in Exports contributed by volume growth of existing products and commercialization of 5 new products ✓ ~39% YoY growth in Domestic in line with the business plan ✓ Gross profit improved by 32% YoY and Gross Margin % broadly maintained at last year level despite change in product mix and reduced MEIS benefit in the 2nd half of FY ✓ EBITDA % improved with strong control on fixed overheads and operating leverage Lower ETR @ 21% due to new SEZ unit getting operational ✓ Significant improvement in Free Cash Flow @ Rs 303 Cr and Gross cash flow at Rs. ~900 Cr with contained capex and improved W/C management Q4 & FY21 Earnings Presentation 4#5PI EXTERNAL Balance Sheet position remained strong showing resilience & growth appetite (Rs in Cr.) Shareholders' Funds FY20 FY21 2,619 5,342 Non Current Liabilities 505 403 Long-term borrowings 399 257 Other long-term liabilities 106 146 Current Liabilities 1,100 1,257 Short-term Borrowings 108 Trade payables 591 796 Other current liabilities 401 461 TOTAL 4,225 7,002 Non Current Asset 2,216 2,509 Net Fixed Asset 2,045 2,343 Good Will 83 83 Non-current investments 18 21 Other Assets 70 62 Current Asset 2,009 4,493 Inventories 799 1,053 Trade receivables 749 852 Cash, Bank & Investments 267 2,327 Other assets 194 Total 4,225 261 7,002 Key Ratios (%) FY20 FY21 Net Sales to Fixed Assets 1.65 1.95 ROCE 22% 26%* Total Debt/Equity 0.16 0.06 * Basis funds deployed into business (excl. QIP proceeds) Q4 & FY21 Earnings Presentation Pi Inspired by Science ✓ Net worth of the Company almost doubled over last year due to increased operating profits and QIP fund raise ✓ Sales to Net working capital improved to 4.13 from 3.52 as at March'21 ✓ Increased inventory levels in line with expected growth and proactive safety stock planning amid Covid Scenario ✓ Investment in capital expenditure at Rs. 459 Cr for FY21 ✓ Surplus Cash net of Debt as on March 21 stood at Rs 2070 Cr (Incl of QIP net proceeds of Rs. 1975 Cr) QIP funds invested with SLR philosophy while final deployment aligned with PI's longer term growth strategy is underway 5#6PI EXTERNAL Key Operational Highlights FY21 Progress on strategic initiatives continues for sustained growth.. Pi Insnired by Science Capacity Build-up 2 manufacturing facilities operationalized Capacity enhancement of upto ~15% in key products IPR Development In FY21, crossed the milestone of having more than 100+ patents filed New Enquiry/Scale-up 4 new products commercialized for exports. Farm Application Services >40 active enquiries at different stages 160K+ acres were covered under Application services, greater than 60% growth YoY Customer Acquisition & Order book 7 new customer relationships initiated in FY21 Order book position >$1.5 billion Novel catalysts, enzyme tech, Technology Scaleup Green chemistry (Ecoscale). Pharma lab commissioned Digitalization, Process Improvements Product Penetration M&A Transaction Successfully integrated Isagro Actively evaluating pharma strategic options Ω Human Capital and Culture New Product Launch Shield (fungicide) launched in Q2 Capital Efficiency Successful launch of Londax Power (Rice herbicide) Deployed Sales Order Application across all zones • Automated Fleet Mgmt. of Application Spraying Services Launched ARIBA sourcing platform, Significant scale up in cotton crop protection portfolio with a growth of >40% Successful scale up of Awkira (wheat herbicide) with 5x growth Multiple HR initiatives kick-started focusing on Leadership development, employee engagement, on-boarding NWC investment reduced by 10%, DSO reduced by 10 days In domestic brands allowing room for strategic inventory for exports to hedge ag. Covid disruption.#7PLEXTERNAL Key performance metrics trend depicts sustainable growth trajectory.. Pi Revenue (Rs Cr) CAGR 25.6% 4,577 3,366 2,841 2,309 EBITDA (Rs Cr) CAGR : 27.2% 1,017 719 576 494 PAT (Rs Cr) Inspired by Science 738 CAGR : 26.2% 410 368 457 FY18 FY19 FY20 FY21 FY18 FY19 FY20 FY21 FY18 FY19 FY20 FY21 Fixed Assets (Rs Cr) CAGR 30.7% 1,369 1,088 2,426 2,128 Net worth (Rs Cr) CAGR : 40.5% 2,619 2,285 1,925 5,343 FY18 FY19 FY20 FY21 FY18 FY19 FY20 FY21 Q4 & FY21 Earnings Presentation 24% 24% FY18 FY19 ROCE 26% 22% FY20 FY21 FY21 - Basis funds deployed into business (excl. QIP proceeds) 7#8PI EXTERNAL Business outlook remains robust.. Targeted expansion backed by solid growth visibility to support momentum Focus on new strategic initiatives to elevate performance P Inspired by Science Business outlook continues to be robust in FY22 supported by new launches and crop diversification Domestic : Focus on portfolio diversification with launch of novel offerings CSM Export: R&D focused approach to drive incremental business Efforts to drive strategic initiatives continues • • • • • • • 5 new launches in FY22, will strengthen rice, cotton and horticulture portfolio Crop diversification of existing products Rice, Horticulture, Cotton, Soybean and Wheat to drive growth Focus to expand application services business with an effort to provide wider solutions to farmers challenges 5-6 pipeline molecules at various stages of development to be commercialized in the coming FY Another MPP is planned to be made ready by Q2FY22, thus enhancing the overall capacities Order book continues to remain robust @ $1.5bn with high visibility of sustainable growth in the next 3-4 years Pursuing inorganic growth opportunities to diversify into adjacencies, widen technology portfolio and de-risk operations •Investing in a new R&D facility for deepening our technological capabilities, de-risking current operations and opening up newer opportunities • Actively evaluating select pharma assets and working with global consulting firm for crystallisation and successfully implementing strategic road map of diversification Amidst challenges owing to covid-19 and related uncertainties, we are confident of achieving >15% growth in FY22 and resolutely progressing on that path Q4 & FY21 Earnings Presentation 8#9PI EXTERNAL Integration of acquired business of Isagro progressing as per plan.. Long term plan in place to unleash full potential The Plan Our Aim Current Update fi Inspired by Science Isagro Asia Domestic Marketing Piece Merge with JIVAGRO (100% Sub of PI) JIVAGRO • Tobe one of the leading players in the horticulture segment in India . >25% CAGR growth over next 4-5 years . . Industry-leading, 25% top-line growth in FY21 YoY, from new horticulture products Leveraged production, commercial & product portfolio synergy to enhance customer experience NCLT order in favour of demerger of Jivagro from Isagro & subsequent operational integration on track with launch in Q1FY22 Jivagro products are ready in new pack & would be available in market Q2'22 onwards Manufactu ring/ CM Piece • Merge with Pl Merger activities are expected to get completed in Q4FY21 Repurposing of mfg site expected to get completed by end of year. MFG SITE Repurpose current mfg set up to align with PI's CSM exports Enhance capacity utilization from current 20-25% to >90% to more than triple the revenue generation in next couple of years. • • 5 pipeline products of PI's exports commercialized in FY21 & ~3 more to be commercialized in FY22 at Isagro mfg site Major synergies with PI's neighboring operations in mfg, EHS, Quality, IT, sourcing, HR, etc realized as per plan Merger of remaining business of Isagro with Pl expected in Q1FY22 Capacity utilisation in Q4FY21 at Isagro facility significantly improved to ~75% Q4 & FY21 Earnings Presentation 9#10PI EXTERNAL Proactive initiatives contained Covid-19 disruption.. SOPs in place with regular reviews / vigilant oversight to ensure safety of employees and continuity of operations... Pi Inspired by Science SOPs have been instituted to focus on alleviation of suffering of the citizenry, reassurance of customer base and maintenance of business momentum Stringent protocols for streamlining operating and non-operating processes are in place. Workplace hygiene and safety steps have been taken to underline minimal disruption to routine functionality Customer commitment is a hallmark of our business approach. Through pro-active communication clients are being reassured and their needs are getting assessed, in real-time basis. Deployment of digital methods last year helped achieve connect with farmers and key constituents of the distribution chain, these are being activated again Manufacturing facility level processes have been augmented. Inventories of critical feedstock and ingredients are being optimally maintained such that the chain of dispatches remains un-broken. Measures to attend to the needs of the associated workforce are also in place Government-based organizations and NGOs are being supported to mitigate hardships and facilitate care, where it is most required. Various employee welfare initiatives such as providing insurances, vaccination drives, safe employee bio-bubble, oxygen concentrators/cylinders, salary advances, etc. are also undertaken MBULANCE Swasthya Sewa FORCE G116 Z 9251 Q4 & FY21 Earnings Presentation 10#11PI EXTERNAL Doing our bit to support govt effort and communities around us to fight Covid-19 Hi-Tech Spraying Leveraged 60 spray machines, sanitized in • 5 states • 34 districts covered • 642 machine working days Sanitizer Production • Sanitizer distribution • benefitted over 1,50,000 people in over 30,000 households 100,000 liters of sanitizer was used for disinfection Distribution of food kits • >12,500 dry ration kits have been distributed to migrant and daily- wage laborers Awareness Campaigns . 3 Mobile Med. Vans • Community outreach programs covered >30,000 people in 64 villages ~1500 people are screened daily Mask Distribution • Distribution of 70,000 masks across the country through PI's women empowerment program near plant operations • Support to Front line workers Arranged PPE & funded medical infra, extending support to 2 govt. hospitals •Also supported Gujarat and Rajasthan govt. healthcare infra Pi Inspired by Science Webinars for Farmers • Around 11,000 farmers benefited through webinars for better yield to overcome economic losses during Covid-19 induced lockdown AMBULANCE Q4 & FY21 Earnings Presentation Swasthya Sewa FORCE G116 Z 9251 11#12PI EXTERNAL "Company's performance was well recognised and earned accolades during the year... Pl has won 3 awards at World Leadership Congress - Business Leader of the Year Awards Business Leader of the Year awarded to Mr. Mayank Singhal, VC & MD, PI Industries Ltd. Corporate Social Responsibility Programme of the Year to PI's DSR initiative CH NATIONAL AWARD FOR EXCELLENCE IN WATER MANAGEMENT 2020 Pi Inspired by Science ds and on IFCI MONG Most Admired Company of the Year Q4 & FY21 Earnings Presentation SIN S CII-National Award for 'Excellence in Water Management 2020' Golden Peacock Award for Corporate Social Responsibility (GPACSR) #1 Rank at the Global HR Excellence Awards by World HRD Congress Dy Revel Charter bsi. Certificate of Registration INFORMATION SECURITY MANAGEMENT SYSTEM-ISO/IEC 27001:2013 Has Caricate PL Ltd 8 Block Sushant Lok Phase 1 Gurugram 122 009 Haryana Teddie 15 705826 wake famation Security Management Testem which completthets of 150/180 Ag Science CSM-Agchamn Manufacturing and Dutribution Services wh rictions Awarded ISO 27001:2013 Certification from British Standards Institute for implementation of information security based on global standards and frameworks This is in accordance with the "Statement of Applicability vidated on 15 New 2018 12#13PI EXTERNAL Corporate Overview & Strategy Recap.. f Inspired by Science#14PI EXTERNAL Our Vision & Values.. VISION "Building on the foundation of trust, we shall be at the forefront of science-led opportunities by delivering innovative solutions." VALUES Pi Inspired by Science TRUST Like the earth, we are dependable. We work with purpose, honesty in integrity of action and fairness in all our dealings SPEED Blazing ahead, like fire, we constantly strive to work with speed in the way we observe, think and act INNOVATION Enlivening, like the air, in the constant quest for the horizon, the never-ending search for a better, newer way to do things; Innovation, for us, is a way of life ADAPTABILITY Adaptive, like water, we are constantly transforming ourselves. Being nimble footed, we are highly responsive to change Q4 & FY21 Earnings Presentation 14#15PI EXTERNAL PI's value proposition Pi Inspired by Science Favorable dynamics driving Indian chemical industry • • . • growth 1 • Global specialty chemicals market expected to grow at 5.4% CAGR¹ Increasing focus on CSM as innovators shift focus to core competencies, developing new active ingredients and outsource production M&A activities boosting specialized CSM players Emerging new areas of innovation such as batteries, coatings, etc. Global supply chain risk diversification: China facing issues-pollution, trade wars, safety issues Business model ready to go beyond Ag-Chem • • • • 2 Business built on end-to- end partnerships with global innovators ~90% CSM revenues from patented molecules; 60%+ domestic revenues from in-licensed molecules Proven capabilities in agrochemicals; now ready to be replicated across other chemicals segments FY21 started with entry into pharma value chain- successfully developed and scaled up an intermediate for a promising Covid-19 drug Offerings across the value chain driven by strategic partnership • • • 3 Integrated and innovative services to provide Comprehensive solutions by partnerships Relationships with 20+ global innovators built on IP protection Strong tangibles: R&D, manufacturing, extensive network of intangibles: Brands • • • 4 Globally certified with use of Technology, 4 manufacturing facilities, 12 multi purpose plants 5 formulation facilities R&D team of 300 researchers and scientists Technology enabled distribution network and relationships with more than 2.5 million farmers/retailers Quality governance, talent & learning skills • . 5 Professionals with expertise across various technical and business functions Senior management team of qualified experienced professionals Well positioned to capture value from changing market landscape Performance over a long term period • 6 Revenue CAGR(FY18- FY20) of 21.6%² EBITDA CAGR(FY18-FY20) of 20.6%³ Pre-tax RoCE of more than • 20% over last 3 years4 Note: (1) FY19-24 CAGR; Source: Frost & Sullivan; (2) Revenue = Revenue from operating - excise duty; (3) EBITDA = Revenue - Cost of Materials consumed - Purchase of Stock in Trade - Changes in Inventories of FG, WIP and stock in trade - Employee Benefits expense - Other Expenses; (4) Pre-tax ROCE %= (EBITDA-D&A) Average Capital Employed (CE); CE=Net Debt + Total Equity. Q4 & FY21 Earnings Presentation 15#16Track record of building several successful businesses, partnerships and industry leading brands.. P Inspired by Science Founded as The Mewar 1946 Oil and General Mills Ltd. Inception 1961 Ag-Chem Formulation and Marketing 1971 Mining later hived off 1976 First Technical Manufacturing plant 1985 Energy Metering, later hived off 1992 Name Changed to PI Industries Limited 1993 Facility at Panoli (Gujarat) 1993 PILL Finance and Investment Ltd. 1995 Polymer Compounding later divested 1996 Custom Synthesis & Manufacturing 2001 1st company in the Ag-chem to implement SAP Q4 & FY21 Earnings Presentation New Business New Partnerships New Geography 2011 GLP Certification 2011 Inauguration of PI-Sony Research Centre 2014 Germany office 2015 2004 PI Life Science Research Ltd. Formulation site setup at Panoli (Gujarat) 2007 Established Subsidiary in Japan 2016 Joint Venture - Solinnos (PI Japan Co. Ltd) New R&D Centre at Udaipur 2008 Started New Rep Office in China (Shanghai) 2017 Joint Venture - PI Kumiai Pvt. Ltd. 2019 M&A acquired IsagroAsia Continuingly creating value propositions for the stakeholders ... 16#17PI EXTERNAL • • • Business model built on the principles of respect for IP and established relationships Domestic Brand Market Leveraging our Pan India network, demonstrating brand building capabilities and experienced team to deliver in- licensed, branded generics & co-marketed products IN-LICENSING Introducing new products, partnering with global innovators Ensure longer product cycles by brand building Develop solutions for the Indian Ag-chem Industry with the partnership approach Leading Ag-chem Distribution Company in India with leading market share in certain crops India's largest CRAMS Company with over 90% Revenue from Patented Products R&D Partnership SYNERGISTIC APPROACH Common Infrastructure Develop knowledge, products, processes and experience in different complex chemistries Cross-Selling Opportunities Pi Inspired by Science Exports Market Leveraging on chemistry process research and manufacturing capabilities catering to Global Innovators; Partnering for IP Creation. · • Custom Synthesis & Manufacturing Early stages of their life cycles • Complex Chemistries • Process development • IP Protection & Generation State of the Art R&D facilities ~300 researchers and scientists • • Accredited for GLPand 'Norms on OECD Principles' by NGCMA To service its customers 1 R&D Facility 4 Manufacturing Sites Domestic Brand Distribution 28 stock points 10,000+ distributors 70,000 retail points 3 Global locations Japan for business development activities China for Sourcing Germany for Knowledge Management Consistent track record of financial performance Non conflicting business model ...well respected by Global Innovators as Partners !!! Q4 & FY21 Earnings Presentation 17#18PI EXTERNAL • Over the years, we aim to build assets to distinguish us from Established relationships based on delivery ⚫ Relationships across the value chain Constantly developing IT tool for business management from R&Dto sales for decision making to achieve customer satisfaction others • Board with 50% independent members Result oriented team • Growing our talent by nurturing, building and acquiring Pro-active approach to asset build-up to reduce turnaround time to cater to customer needs • • Known for respect for IP Pi • Technical capabilities and sustainability Recognized for best practices for EHS & governance Customers Process People Infrastructure 2.5 mn farmers/retailers ⚫ 70,000 retailers, 10,000+ distributors pan India 20+ Global innovator Partners Several decades of working with Japan ⚫ Trusted business partnerships-many of them more than a decade old • Web based integrated mobile tools to connect with stakeholders ⚫ ELNfor R&D ⚫LIMS-for Quality & • Production • DCS systems with analytics ESS & EPM System thru SAP • Built in IT security SSC Shared Service Centre EHSmanagement system & practices • >3000 Employees • 51% workforce <35 years • >40% of total workforce are atleast post-graduate • ~300 researchers and . scientists ⚫ > 130 PhDs • 35% of our top management > 5 years tenure with Pl • • • • · 4 manufacturing facilities 1 R&D Campus 12 Multi Purpose plants 5 formulation setups 28 stock points Pan India International presence. Japan, Germany and China • IT enabled and system driven Information and communication system Layout, systems and management processes In house capabilities for design, flexibility & scalability · • • • Intangibles Know for its Governance IP Protection Trust No conflict Established strong brands with majority brands as leaders Farmer Connect Partner of choice with alignment of customerneeds and business strategy Focus on EHS We continue to invest to retain our leadership position with a focus on Sustainability ... Q4 & FY21 Earnings Presentation 18#19PI EXTERNAL Presence across the agchem value chain Strong focus on customer needs and continuous innovation Pi Inspired by Science CSM Exports Domestic Brands Discovery Development Scale-up Manufacturing Evaluation & Trials Regulatory services & Registrations Marketing & Distribution Quality Objective to be high quality producer Control all processes that impact quality of the end product Q4 & FY21 Earnings Presentation I Customer Needs Efficiency Target driven Ownership at sub- functional level Business Strategy Consistent Quality Cost Competitiveness Speed of execution, delivery Reliable & Adaptable Real-time monitoring & review Continuous improvement innovatively Throughput Ensure consistent, reliable delivery Continuous de-bottlenecking Automation • Environment & Safety To set bench marks Address at source Safety first culture Innovation Protect and build IP 19#20PI EXTERNAL Differentiated domestic distribution model Driven by unique solutions thru global partnerships, brands building capabilities and market reach Strong Partner 40+ years experience 20+ Global Innovators More than 50 years Creating Market Leading Brands Significant revenue from Brands Ranked No 1 or 2 in the market, Some brands are more than a decade old Strong Pipeline Molecules based on crop solutions and Indian needs FOCUS ON INNOVATION Pi Inspired by Science Farmers & Extensive Distribution Network 28 stock points; 10K+ distributors; 70K+ retail points Extension & product development & stewardship (team experience in handling complex new-age premium chemistries) Strong relationship with stakeholders Policy level by participation Domestic Business - Brands Evaluation & Trials Regulatory services & Registrations Marketing & Distribution PROCURE REPEAT BUSINESS UNDERLYING PRINCIPLES RESPECT FOR IP DEVELOPMENT REPUTATION OF TRUST & RELIABILITY FORGE RELATIONSHIP Digi-tech @Core Engagement Efficiency Excellence Crop Solutions Farmers Q4 & FY21 Earnings Presentation BENEFITS OF CROSS SELLING OPPORTUNITIES • Crop solution approach focussing farmer & using ICT (Information, Communication and Technology) Organization structure empowered with digi tech to support and demonstrate value delivery to farmers Online analytics tools for farmers and employees Innovative Ideas and branding for enhancing product life cycle Experience of successfully managing transition of products from patented to generic Application services for development & engagement Channel Enablers 20#21CUFSTED Synthesis & Manufacturing (CSM) model is centered around our technological capabilities, high sustainability quotient and world class infrastructure Pi Inspired by Science To be the lifelong Partner of Choice for the Global Chemicals Industry by building innovative, knowledge based solutions through speed, efficiency, straightforwardness & just dealings, respect for intellectual property, society & environment Ag Chem Electronics Imaging Addatives Partner of Choice OUR FOCUS Service Lines Who High value Niche player / boutique industry-leading supplier Low - Mid volume Process technology Complex chemistry How Research & Development Analytical Research & Services • IP (generation / protection) Longevity of meaningful engagement • Process Development Engineering • High Potential A marriage of competent equals • Pl as 1 or 1 of 2-3 sources Consultative solution rendering & outsourcing process • Process Scale up Commercial Production Customer as innovators . Reliability of services Performance Pharma FINE CHEM PI has all that is required to be the "Partner of Choice" Q4 & FY21 Earnings Presentation Pre-launch Knowledge Partnership On-patent growing • • • " Focus on the early stage novel molecules Solutions Characterized by Specifications with control limits Reliability & predictability Repeatability On-patent mature In • Technology . Process Commercial operations Supply chain customer • End applications Off-patent Early-to-market Late-to-market ================== ". "1 ===" Continuous innovation for process and operational improvement. 21#22PI EXTERNAL Global tailwinds offering opportunities for aggressive and multi-pronged growth strategy Inorganic... Market • Expansion • Creation Segments . Operation excellence • Brands • Value added Technolgy Organic Grow Smart Build Customer Intimacy Product & services IP • • • Asset Customer relationship Management Process Customers Value-chain - Add Products Digitization Strategic tie ups De risk & Create De risk... Manufacturing concentration • New formulation of existing products • • Pi Inspired by Science Create... Process Innovation Biological process development Formulation Combinations with Partners Biological • New formulations - Process Chemistry Digital Customer engagement Block Builders • Products Assets • Niche vertical with a future Pharma/Specialty chemical High growth application areas having synergy Disruptive technologies in chemistry & process engineering Inorganic Value creation Process engg • Flow Digital • Information integration • Decision tools Deepening our technological capabilities to open new horizons.. Prudent financial management in place to ensure that long term shareholder value creation remains at the heart of the strategy... Q4 & FY21 Earnings Presentation 22#23PI EXTERNAL Domestic agri input market is expected to grow fast and Pl is well positioned to capitalize this opportunity.. P₁ Inspired by Science BEVED Strong novel offerings with focus on in-licensing BIOVITA KITA 8-10% projected CAGR between 2020 to 2025 Ingredients in place for PI to capitalize this opportunity 3/4 exclusive launches VIDRANTO OSHEEN • FORRITON OG 25+ products in the pipeline SANIPED INRO LUR LOOK WICKET PINO MELSA Supported by new product launches Dedicated verticals for horticulture crops through Jivagro >20% CAGR growth estimated over next 4-5 years . Source: FICCI Report on Indian Speciality Chemicals Industry Q4 & FY21 Earnings Presentation Extensive Distribution Network Robust brand building capabilities Leadership position in key crops 23#24PI EXTERNAL With Indian gaining good market share of the global Specialty Chemical market, Pl is consolidating its position with diversification into adjacencies.... "Pi Indian Specialty Chemicals Industry size (USD bn) 64 32 18 CAGR 11.7% CAGR 12.4% 2015 2019 2025 Factors that will elevate growth for Indian Companies India's emergence as an export hub for global innovators Increase in outsourcing manufacturing Leadership position in select niche activities to India molecules and chemistries Benefits accruing out of supply chain diversification Source: FICCI Report on Indian Speciality Chemicals Industry Q4 & FY21 Earnings Presentation Focus on Inspired by Science Global Specialty Chemicals Industry size (USD bn) 1,171 805 610 CAGR 5.7% CAGR 6.4% 2015 2019 Advantage PI Industries 2025 green chemistry through adoption of sustainable manufacturing practices Relationship based approach built on trust and IP protection Significant investments in technological advancements Proven manufacturing capabilities and expertise Complete control position and visibility around scale-up of molecules 24#25Pi Inspired by Science Το PI EXTERNAL Our CSR efforts have focused on Community welfare & PI's CSR strategy focuses on: Environment Creating a positive impact for marginalized communities via environmentally sustainable approach Interventions align with several Sustainable Development Goals (SDG) Continuous life cycle evaluation of products and product stewardship to minimize eco- impact Implementation Sustainable Agriculture Practice Healthcare, Hygiene and Sanitation Interventions Women Empowerment Education Interventions Skill Development 700K+ Hectares of Farmlands benefitted by DSR technique thereby saving 1.6 trillion litres of Water annually 100K+ Lives impacted using Mobile Healthcare Vans under PI's 'Swasthya Seva" Initiative and Blood Bank services 15K+ Women across 82 villages in Bharuch Area benefitted through PI's women empowerment program 18K+ Govt. school children across 125 Schools benefitted through PI's Learning Enhancement Programmes 1.8K+ Youth employed through large scale Skill Development Programmes Key Programmes and Initiatives Water conservation through sustainable agriculture practices & farm engagement activities SWASTHYA Seva Initiative - Aim to provide access to preventive, promotive & curative health care to underprivileged Learning enhancement programmes for government school children in 135 schools Certified vocational training & employability linked skill enhancement program for underprivileged youth Entrepreneurship development & livelihood promotion through sustained agriculture, dairy value chain & skill training for rural women Community Drinking Water Initiative and construction of school toilets Q4 & FY21 Earnings Presentation 3 25#26PI EXTERNAL Thank you PI Industries Ltd. Corporate Off: 5th Floor, Vipul Square, B Block, Sushant Lok, Phase - 1, Gurgaon-122009 (Har), India; Tel: +91 124 6790000, Fax: +91 124 4081247. Regd. Off: Udaisagar Road, Udaipur - 313001; Tel: +91 294 2491451-5, Fax: +91 294 2491946. www.piindustries.com fi Inspired by Science